<DOC>
	<DOCNO>NCT02388516</DOCNO>
	<brief_summary>There grow body data suggest vitamin D modulate host 's immune response acute respiratory infection ( ARI ) . The primary aim study determine whether maternal vitamin D3 supplementation versus placebo decrease incidence rate microbiologically confirm viral-associated ARI among infant Dhaka , Bangladesh . Secondary outcome include : A ) incidence ARI associate specific major pathogen , B ) incidence clinical ARI ( without need positive microbiology ) , C ) quantitative density pneumococcal carriage . Infants follow birth 6 month life . Among infant meet least one specific case definition ARI ( see 'Detailed Description ' section ) , nasal swab specimen collect . Respiratory sample analyze real-time polymerase chain reaction ( qPCR ) identify 7-virus panel ( influenza A B , respiratory syncytial virus , human metapneumovirus , adenovirus , parainfluenza type 1 , 2 , 3 ) plus quantitative density S. pneumonia .</brief_summary>
	<brief_title>Maternal Vitamin D Acute Respiratory Infections Infancy</brief_title>
	<detailed_description>In study , acute respiratory infection ( URTI and/or LRTI ) clinically define : A ) Upper respiratory tract infection ( URTI ) A new-onset illness consist least two follow clinical criterion time surveillance week : - Caregiver-reported cough ; - Caregiver-reported rhinorrhea ; - Caregiver-reported nasal congestion ; , - Measured axillary temperature great equal 37.5Â°C . B ) Lower respiratory tract infection ( LRTI ) 1 . New onset clinically-diagnosed LRTI : - Caregiver-reported cough AND/OR difficulty breathe surveillance week ; AND , - Observed low chest wall indrawing AND/OR elevate respiratory rate ( 60 breath per minute great infant 59 day age , 50 breath per minute great infant 60 day age old ) 2 . Hospitalized LRTI - Hospitalization physician diagnosis pneumonia bronchiolitis</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Infants born woman enrol MDIG trial ( NCT01924013 ) . Maternal inclusion criterion ( time enrolment ) : At least 18 year age 17 24 complete week gestation Intends permanently reside trial catchment area least 18 month Family plan reside catchment area first 6 month postnatal Provides write informed consent participation Mother withdrawn MDIG trial prior delivery Failure provide consent participation substudy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>26 Weeks</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Bangladesh</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Acute Respiratory Infections</keyword>
	<keyword>Infancy</keyword>
	<keyword>Pregnancy</keyword>
</DOC>